Clinical Trials Logo

Opioid-induced Constipation clinical trials

View clinical trials related to Opioid-induced Constipation.

Filter by:

NCT ID: NCT01623609 Completed - Clinical trials for Opioid Induced Constipation

Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

Start date: July 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to demonstrate the Bioequivalence, assess food administration on the Pharmacokinetics with naloxegol.

NCT ID: NCT01459926 Completed - Clinical trials for Opioid Induced Constipation

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

Start date: November 2011
Phase: Phase 2
Study type: Interventional

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects with Opioid-Induced Constipation

NCT ID: NCT01443403 Completed - Clinical trials for Opioid Induced Constipation

A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy

Start date: August 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy and safety of S-297995 for the treatment of opioid-induced constipation in subjects with non-malignant chronic pain receiving opioid therapy for ≥3 months

NCT ID: NCT01401985 Completed - Clinical trials for Opioid Induced Constipation

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

Start date: October 2011
Phase: Phase 2
Study type: Interventional

A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation

NCT ID: NCT01382797 Completed - Clinical trials for Opioid-induced Constipation

ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

Start date: August 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and efficacy of ALKS 37 when administered daily for 4 weeks to adults with Opioid-induced Constipation (OIC).

NCT ID: NCT01368562 Completed - Clinical trials for Opioid-induced Constipation

Compassionate Use Study of Methylnaltrexone

Start date: January 24, 2003
Phase: N/A
Study type: Interventional

This is an open label compassionate use study of subcutaneously administered methylnaltrexone (MNTX) in participants with advance medical illness and opioid-induced constipation.

NCT ID: NCT01207427 Completed - Clinical trials for Opioid Induced Constipation

Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Start date: October 14, 2010
Phase: Phase 2
Study type: Interventional

Morphine and related opioid analgesics are known to slow gastrointestinal (GI) motility and reduce intestinal secretion through their binding to μ opioid receptors (MORs) within the GI tract. The most common symptoms associated with the effects of opioids are constipation and nausea and/or vomiting. Moreover, constipation is a common and distressing side effect of long-term opioid therapy. The primary objective of this study was to compare ADL5945, a MOR antagonist, with placebo in the treatment of opioid-induced constipation (OIC) in adults taking long-term opioid therapy for chronic noncancer pain.

NCT ID: NCT01186770 Completed - Clinical trials for Opioid-Induced Constipation

A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

Start date: September 1, 2010
Phase: Phase 3
Study type: Interventional

MNTX 3201 is a Phase 3, international, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of oral MNTX for the treatment of opioid induced constipation in participants with chronic, non-malignant pain.

NCT ID: NCT01109511 Completed - Postoperative Pain Clinical Trials

A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy

Start date: March 1, 2010
Phase: Phase 4
Study type: Interventional

Objectives: Primary objective: - To demonstrate that the treatment with OXN PR tablets up to 72 hrs after surgery is superior to the treatment with OxyPR with regards to constipation in subjects with postoperative pain after laparoscopic hysterectomy based on interviews 24h, 72 h and 1 week postoperatively. The secondary objectives: - Analgesic effect (including registration during the first 24 hrs) - To asses the frequency of pain rescue mediation use (in the double-blind phase, 0-72 hrs) - Frequency of nausea and vomiting - Frequency of other adverse events - Appetite - Mobilization The exploratory objectives: - Overall patient satisfaction at 24, 72 hrs and 1 week

NCT ID: NCT01100151 Completed - Clinical trials for Opioid-induced Constipation

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of RDC-1036 (ALKS 37) in adults with opioid-induced constipation (OIC) following repeat dose administration